Expansion of bariatric surgery in the UK ‘challenging’ due to significant upfront economic investmentExpanding the capacity of bariatric and metabolic surgery (BMS) capacity in England beyond a small proportion of the eligible population...
REBORN study: How to prioritise patients for BMS leading to the appropriate selectionImprovements in the physical component of quality of life (QoL) after metabolic and bariatric surgery (MBS) varies for patients with...
Expansion of bariatric surgery in the UK ‘challenging’ due to significant upfront economic investment
Bariatric surgery may help people with obesity manage hypertensionPeople living with obesity who underwent bariatric surgery were more likely to control their hypertension over a one-to-five-year...
AEON stapler non-inferior to Tri-Staple with preloaded buttress material in achieving haemostasis and maintaining staple-line integrityThe AEON stapler (Lexington Medical) is non-inferior to the Tri-Staple (Medtronic) in achieving haemostasis and maintaining staple-line...
FDA grants De Novo marketing authorisation to GT Metabolic Solutions for its magnet compression anastomosis technologyGT Metabolic Solutions has announced its first-generation MagDI System for side-to-side duodeno-ileal anastomosis has been granted De...
No increased risk of mental health issues among those using semaglutide for weight lossTaking the weight loss medication semaglutide does not increase the risk of depressive symptoms, suicidal thoughts or suicidal behaviour...
No association between GLP-1s and suicideA study led by researchers at Karolinska Institutet, Sweden, has found there is no association between glucagon-like peptide-1 receptor...
Journal watch 4/09/2024Welcome to our weekly round-up of the latest bariatric and obesity-related papers published in the medical literature. As ever, we have...
REBORN study: How to prioritise patients for BMS leading to the appropriate selectionImprovements in the physical component of quality of life (QoL) after metabolic and bariatric surgery (MBS) varies for patients with...
Expansion of bariatric surgery in the UK ‘challenging’ due to significant upfront economic investmentExpanding the capacity of bariatric and metabolic surgery (BMS) capacity in England beyond a small proportion of the eligible population...
Pneumonia and respiratory causes the largest causes of long-term mortality after BMSPneumonia and respiratory causes were found to be the largest causes of long-term mortality after bariatric and metabolic surgery (BMS),...
Blocking circulating protein interferon-γ pathway could lead to potential treatment for metabolic liver diseaseUniversity of Massachusetts Medical School researchers have identified a novel pathway in the progression of metabolic liver disease that...
Semaglutide reduces COVID-19 related deaths in patients with obesity and CVD Semaglutide reduced the rates of COVID-19-related adverse events, including death, in those who had overweight or obesity and established...
European Society of Cardiology Obesity Consensus StatementThe European Society of Cardiology (ESC) Clinical Consensus Statement on Obesity and Cardiovascular Disease, presented at this year's ESC...
FDA grants De Novo marketing authorisation to GT Metabolic Solutions for its magnet compression anastomosis technology
Olympus launches new Powerseal Sealer/Divider 5mm devices extending advanced bipolar surgical energy portfolio
Lilly releases Zepbound (tirzepatide) single-dose vials, expanding supply and access for adults living with obesity